The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Caris Discovery™, the therapeutic research arm of Caris Life Sciences® (Caris), announced a multi-year strategic partnership with Merck KGaA, ...
read more
Myrtelle Inc. announced that the FDA granted Regenerative Medicine Advanced Therapy (RMAT) Designation to the Company's lead gene therapy product ...
read more
Ginkgo Bioworks announced the acquisition of Modulus Therapeutics' cell therapy platform assets, including their chimeric antigen receptor (CAR) and ...
read more
Ipsen and Sutro Biopharma announced an exclusive global licensing agreement for STRO-003. STRO-003, an antibody-drug conjugate (ADC) in the final ...
read more
Agilent Technologies Inc. and the University of California San Diego (UC San Diego), one of the top-ranked public research universities in the world, ...
read more
Wednesday, March 27, 2024
ProBioGen, a globally recognized and experienced Contract Development & Manufacturing Organization (CDMO), proudly announces a partnership with ...
read more
Bristol Myers Squibb announced that the European Commission (EC) has granted approval to Abecma® (idecabtagene vicleucel; ide-cel) for the treatment ...
read more
Charles River Laboratories International, Inc. and National University of Singapore’s (NUS) Yong Loo Lin School of Medicine (NUS Medicine), a leading ...
read more
Wednesday, March 20, 2024
Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, today announced it has signed an agreement to acquire ...
read more
Wednesday, March 20, 2024
Celanese Corporation, a specialty materials and chemical company, and Secarna Pharmaceuticals GmbH & Co. KG, a European antisense drug discovery and ...
read more
Cellipont Bioservices, a cell therapy Contract Development and Manufacturing Organization (CDMO), and Wugen, Inc., a clinical-stage biotechnology ...
read more
Charles River Laboratories International, Inc. announced an AAV9 production program agreement. As part of Charles River’s Cell and Gene Therapy (CGT) ...
read more
Merck announced the completion of the acquisition of Harpoon Therapeutics, Inc.. Harpoon is now a wholly-owned subsidiary of Merck, and Harpoon’s ...
read more
AbCellera and Biogen Inc. have entered into a strategic collaboration to discover antibodies for a novel target that enables the delivery of ...
read more
PolTREG S.A. announced it has received CGMP certification from Poland’s Chief Pharmaceutical Inspectorate, allowing it to produce cellular therapies (...
read more